Catalys Pacific
Tokyo, Tokyocatalyspacific.com
Overview
An independent venture capital firm founded in 2019 that focuses on early-stage investments in life sciences, including biotherapeutics, MedTech, and diagnostics. The firm aims to bridge the innovation ecosystems of Japan and the United States, creating and investing in biotech companies.
Portfolio Companies
6
Website
catalyspacific.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Crystalys Therapeutics | Jul 2026 | Series B | Co-investor |
| Crystalys Therapeutics | Sep 2025 | Series A | Lead |
| Pathalys Pharma | Aug 2024 | Series B | Co-investor |
| Renalys Pharma | Jul 2024 | Series A | Lead |
| Arialys Therapeutics | Sep 2023 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
